TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ACB
ACB logo

ACB

AURORA CANNABIS INC

Next earnings Aug 4, 2026 · consensus $-0.01 EPS, $72.9M rev

Sell
$2.84
▼ -1.39%
$2.84▼ -31.57%
over 1Y
L $2.76H $6.23
Today-1.4%
1W+2.9%
1M-19.1%
3M-17.4%
YTD-34.6%
1Y-31.6%
OverviewValuationQualityFilings
Rating
Sell
Quality
F
Valuation
Fair value
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Buy

Mixed signals in the latest filings.

AURORA CANNABIS INC shows limited reported revenue.

On these fundamentals, ACB screens as SELL on the SEC figures.

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 11:27 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Is ACB a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

No income data filed.

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$176M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+3.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-06-112026-06-11open ↗40-FPeriod ending 2026-03-312026-06-11open ↗6-KPeriod ending 2026-05-282026-05-28open ↗6-KPeriod ending 2026-05-212026-05-21open ↗6-KPeriod ending 2026-05-142026-05-14open ↗6-KPeriod ending 2026-04-282026-04-28open ↗6-KPeriod ending 2026-04-162026-04-16open ↗6-KPeriod ending 2026-04-152026-04-15open ↗6-KPeriod ending 2026-03-302026-03-30open ↗6-KPeriod ending 2026-02-172026-02-18open ↗6-KPeriod ending 2026-02-122026-02-12open ↗6-KPeriod ending 2026-02-042026-02-04open ↗

Quality score

F
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial health—
MomentumF
2.7652-week6.23
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals

Frequently asked

Is AURORA CANNABIS INC (ACB) a buy?
ACB currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
What is AURORA CANNABIS INC's quality score?
ACB scores 20.224943964137047/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001683541, latest 6-K filed 2026-06-11) · EODHD · as of 7/4/2026, 3:27:23 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Congressional trades

all activity →

Disclosed under the STOCK Act

2021-02-19John A. YarmuthBuy$1.00K–$15.0KPTR ↗
2020-11-15John A. YarmuthBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?Bullish
finance.yahoo.com· 2026-06-24
Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update ReportBullish
finance.yahoo.com· 2026-06-15
Aurora Cannabis Q4 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-06-11
Here are the major earnings before the open Thursday
seekingalpha.com· 2026-06-10
Quant snapshot: United Natural Foods, Designer Brands lead top-rated names as MIND Technology, BARK lagBullish
seekingalpha.com· 2026-06-07
Earnings week ahead: ORCL, ADBE, FCEL, ACB, CHWY, and moreBullish
seekingalpha.com· 2026-06-07

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score20 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 10d
Neutral
+0.03
vs typical · 12 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.